Why Attendees Keep Coming Back to PepTalk
PepTalk isn’t just a conference—it’s a community. Year after year, participants return for the cutting-edge science, practical insights, and meaningful connections that drive innovation in protein engineering, expression, purification, and analytics. Whether you’re a first-time attendee or a long-time veteran, you’ll find unmatched opportunities to learn, collaborate, and shape the future of biotherapeutics.
See what attendees have to say.
PepTalk was an invaluable experience, offering a wealth of talks packed with relevant insights on new protein modalities. The focused sessions made it easy to navigate the agenda, ensuring I could find the most relevant discussions and connect with the right people. I left with fresh perspectives and actionable takeaways that will directly impact my work.
-Robert C., Senior Scientist, AstraZeneca
Attending and presenting at PepTalk was a great decision for our small company. The other attendees were very open about their scientific work and shared suggestions not only about protein production but also leading teams, managing data, and a range of complementary topics. The interactions we had have already prompted ideas for collaborations and adopting new technologies.
-Jarrod S, R&D Group Leader, ExpressionEdits Ltd
PepTalk is the most diverse audience across protein expression, production and characterization in the field. Having these diverse perspectives all in one place is invaluable.
-Edward K., Senior Director, Small Molecule Discovery, Leash Bio
A wonderful mix of scientists from academia and industry, very open discussions, relaxed and inspiring atmosphere! I believe the interaction with the BioLogic conference was novel and definitely great!
-Iskandar D., Principal Scientist & Business Development Manager, Validogen GmbH
I had an amazing time at my first Peptalk in San Diego! An absolute pleasure to spend nearly a full week chatting and exchanging ideas with the Protein Whisperers on this side of the pond!
-Christopher C., Director and Head of Protein Sciences, CHARM Therapeutics